Ignite Creation Date:
2025-12-24 @ 12:48 PM
Ignite Modification Date:
2026-02-20 @ 1:35 PM
Study NCT ID:
NCT02811861
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-01
First Post:
2016-06-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Sponsor:
Organization: